Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, received CDMO Leadership Awards in all six categories - Capabilities, Compatibility, Expertise, Quality, Reliability, and Service for both...
read more
DifGen Pharmaceuticals LLC announced that it has signed and closed an all-cash transaction through its subsidiary Aveva Drug Delivery Systems Inc. to purchase the operating and manufacturing assets of an FDA-registered manufacturing facility located ...
read more
Cellipont Bioservices, a cell therapy Contract Development and Manufacturing Organization (CDMO), and Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies to treat a broad range of hematological and ...
read more
Syngene International, a global contract research, development and manufacturing organization (CRDMO), announced that its newly upgraded biologics facility - Unit 3 - would be operational for clinical and commercial supply in the second half of 2024.
read more
Noramco announced its launch of the Noramco Group, a newly created comprehensive North American-based supply chain solution including subsidiaries Purisys, Noramco, and the newly acquired drug product CDMO, Halo Pharma.
read more
Aptar Pharma, part of AptarGroup, Inc., announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site.
read more
Charles River Laboratories International, Inc. announced an AAV9 production program agreement. As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Navega will have access to established contract development and ...
read more
Bright Green Corporation (BGXX) announced it will install a 102-megawatt solar field to power the electricity and heating requirements for the new $250 million Dalsem expansion project and commits to switch the existing facility that currently burns ...
read more
Wednesday, March 13, 2024
Allumiqs and Prolytix, announced a long-term, strategic partnership focused on delivering collaborative and integrated solutions to help customers optimize drug development pipelines.
read more
Wednesday, March 13, 2024
LGM Pharma, a provider of API and CDMO services for the full drug product lifecycle, announced a significant enhancement of its capabilities: a 50% expansion and an investment exceeding $2 million in its standalone offering for Analytical Testing ...
read more
Mikart LLC announced the successful validation of its liquid product within its innovative Liquid and Suspension Suite for an Oral Solution Program.
read more
Alcami Corporation announced a new strategic partnership with Tanvex CDMO, a biologics developer offering pre-clinical to commercial biologic CDMO services.
read more
Adare Pharma Solutions announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear mixer granulator to complement existing fluid bed capabilities.
read more
The U.S. FDA announced it is requesting $7.2 billion as part of the President's fiscal year (FY) 2025 proposed budget.
read more
SGS announced that its Fairfield laboratory has earned its ISO/IEC 17025:2017 certification.
The globally recognized accreditation, together with Fairfield’s extensive experience as a GMP FDA approved laboratory, allows SGS to clearly demonstrate ...
read more